Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Reduced Venetoclax Exposure in Patients With Acute Myeloid Leukemia in Complete Remission

NCT07163793 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT07163793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07163793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Reduced Venetoclax Exposure in Patients With Acute Myeloid Leukemia in Complete Remission
Lead sponsor
Northwell Health
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 26, 2025
Completion date
February 29, 2028
Enrollment
41 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia in remission